Endocrinology Health DKA concerns remain paramount in FDA’s denial of sotagliflozin for type 1 diabetes admin January 15, 2025 0 January 13, 2025 8 min read Add topic to email alerts Receive an email when... Read MoreRead more about DKA concerns remain paramount in FDA’s denial of sotagliflozin for type 1 diabetes